T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution

被引:43
作者
Tomita, S
Jiang, HB
Ueno, T
Takagi, S
Tohi, K
Maekawa, S
Miyatake, A
Furukawa, A
Gonzalez, FJ
Takeda, J
Ichikawa, Y
Takahama, Y
机构
[1] Univ Tokushima, Div Expt Immunol, Inst Genome Res, Tokushima 7708503, Japan
[2] Kagawa Med Univ, Dept Biochem, Kagawa, Japan
[3] Univ Tokushima, Dept Immune Syst Dev, Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Tokushima 7708503, Japan
[4] Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan
[5] Osaka Univ, Dept Social Environm Med, Grad Sch Med, Osaka, Japan
[6] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.171.8.4113
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The arylhydrocarbon receptor nuclear translocator (ARNT) is a member of the basic helix-loop-helix, PER-ARNT-SIM family of heterodimeric transcription factors, and serves as a dimerization partner for arylhydrocarbon receptor (AHR) and hypoxia-inducible factor-1alpha. To assess the function of ARNT in T cells, we disrupted the Arnt gene specifically in T cells of mice by conditional gene targeting using T cell-specific p56(lck)-Cre (Lck-Cre) transgenic Arnt-floxed mice. Thus generated, T cell-specific Arnt-disrupted mice (Lck-Cre;Arnt(flox/Delta) transgenic mice) exhibited complete loss of the expression of ARNT protein only in T cells, and were viable and appeared normal. The Arnt-disrupted T cells in the thymus were phenotypically and histologically normal. The Arnt-deficient T cells in the spleen were capable of responding to TCR stimulation in vitro. However, unlike normal mice in which exposure to the environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), an AHR ligand, resulted in thymic involution, the thymus of Lck-Cre;Arnt(flox/Delta) mice were resistant to TCDD treatment in vivo. In contrast, benzo(a)pyrene, another AHR ligand, still caused thymic involution in Lck-Cre;Arnt(flox/Delta) mice. Finally, fetal thymus organ culture using Lck-Cre;Arnt(flox/Delta) and K5-Cre;Arnt(flox/Delta) (epithelial cell-specific Arnt-disrupted mice) showed that thymocytes rather than thymic epithelial cells are predominantly responsible for TCDD-induced thymic atrophy. Our results indicate that ARNT in T lineage cells is essential for TCDD-mediated thymic involution.
引用
收藏
页码:4113 / 4120
页数:8
相关论文
共 58 条
[1]   CLONING OF THE AH-RECEPTOR CDNA REVEALS A DISTINCTIVE LIGAND-ACTIVATED TRANSCRIPTION FACTOR [J].
BURBACH, KM ;
POLAND, A ;
BRADFIELD, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8185-8189
[2]  
CARLSTEDTDUKE JMB, 1979, CANCER RES, V39, P3172
[3]   TISSUE-SPECIFIC EXPRESSION OF THE RAT AH-RECEPTOR AND ARNT MESSENGER-RNAS [J].
CARVER, LA ;
HOGENESCH, JB ;
BRADFIELD, CA .
NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3038-3044
[4]  
DEHEER C, 1994, EXP CLIN IMMUNOGENET, V11, P86
[5]   ALTERATIONS IN THE CORTICAL THYMIC EPITHELIUM OF RATS AFTER INVIVO EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) - AN (IMMUNO)HISTOLOGICAL STUDY [J].
DEWAAL, EJ ;
SCHUURMAN, HJ ;
LOEBER, JG ;
VANLOVEREN, H ;
VOS, JG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 115 (01) :80-88
[6]   cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization [J].
Ema, M ;
Suzuki, M ;
Morita, M ;
Hirose, K ;
Sogawa, K ;
Matsuda, Y ;
Gotoh, O ;
Saijoh, Y ;
Fujii, H ;
Hamada, H ;
FujiiKuriyama, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (02) :588-594
[7]   IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR [J].
FERNANDEZSALGUERO, P ;
PINEAU, T ;
HILBERT, DM ;
MCPHAIL, T ;
LEE, SST ;
KIMURA, S ;
NEBERT, DW ;
RUDIKOFF, S ;
WARD, JM ;
GONZALEZ, FJ .
SCIENCE, 1995, 268 (5211) :722-726
[8]   Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity [J].
FernandezSalguero, PM ;
Hilbert, DM ;
Rudikoff, S ;
Ward, JM ;
Gonzalez, FJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 140 (01) :173-179
[9]  
FINE JS, 1990, J IMMUNOL, V144, P1169
[10]  
GASIEWICZ TA, 1984, MOL PHARMACOL, V26, P90